Top picks in English

Virogates lands a customer - and counts them as two

In 2020, Lillebælt Hospital will start using Virogates' inflammation test in its intesive care departments. In terms of the goal of having 40 customers before 2021, the hospital counts as two, and the CEO is excited about the revenue potential and the signal the deal sends. 
Virogates CEO Jakob Knudsen has ended the year by entering a deal which will start increasing revenue next year - and the signaling value is already a benefit
Virogates CEO Jakob Knudsen has ended the year by entering a deal which will start increasing revenue next year - and the signaling value is already a benefit
af ULRICH QUISTGAARD

Christmas has come early for the CEO of Danish diagnostics company Virogates, Jakob Knudsen, who has entered a contract with Lillebælt Hospital over the use of the firm's inflammation test, Suparnostics Turbilatex.

Allerede abonnent?Log ind her

Læs hele artiklen

Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

Med din prøveperiode får du:

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
    • Skal indeholde mindst 8 tegn samt tre af disse: Store bogstaver, små bogstaver, tal, symboler
    Skal indeholde mindst 2 tegn
    Skal indeholde mindst 2 tegn

    Få fuld adgang til dig og dine kollegaer

    Start et gratis virksomhedsprøveabonnement

    Del artikel

    Relaterede artikler

    Tilmeld dig vores nyhedsbrev

    Vær på forkant med udviklingen. Få den nyeste viden fra branchen med vores nyhedsbrev.

    Nyhedsbrevsvilkår

    Forsiden lige nu

    Læs også

    Job